Matches in SemOpenAlex for { <https://semopenalex.org/work/W2408804921> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2408804921 endingPage "32" @default.
- W2408804921 startingPage "2923" @default.
- W2408804921 abstract "In August 1988 a randomised phase III multicenter trial was started in order to compare cisplatinum/treosulfan (PT) with standard cisplatinum/cyclophosphamide (PC) in advanced ovarian carcinoma, aiming at lower toxicity and maintained efficiency.Five hundred and nineteen patients were enrolled into the protocol. Final evaluation after a median observation time of more than five years was made in July 1996 and included 398 eligible patients, of whom 366 were evaluable regarding efficiency and 290 in respect of toxicity. The tumour stages were classified as FIGO II in 53, FIGO III in 244 and FIGO IV in 68 patients. The patients were stratified regarding post-operative tumour burden.Hematological and gastrointestinal toxicity WHO > = 3 were comparable between the two study arms though a significant difference could be demonstrated regarding alopecia (PT 8% vs. PC 47% after six cycles). The median time to progression as the main efficiency item was in favour of the study schedule (PT 20.6 vs. PC 15.1 months) while significant differences were neither observed in the whole study group nor in the analysed subgroups (R0, < 2 cm, > = 2 cm). The same held true for overall survival.PT may be recommended as a less toxic substitute for the former standard PC. After the acceptance of paclitaxel/cisplatin as a new standard, the role of treosulfan should be investigated regarding adjuvant therapy in patients without residual tumor, as a potential partner in triple or sequential treatment and in second-line treatment." @default.
- W2408804921 created "2016-06-24" @default.
- W2408804921 creator A5007920312 @default.
- W2408804921 creator A5013581129 @default.
- W2408804921 creator A5032813803 @default.
- W2408804921 creator A5039080671 @default.
- W2408804921 creator A5047484440 @default.
- W2408804921 creator A5054137171 @default.
- W2408804921 creator A5054580261 @default.
- W2408804921 creator A5063493469 @default.
- W2408804921 date "2003-01-18" @default.
- W2408804921 modified "2023-09-26" @default.
- W2408804921 title "Treosulfan in the treatment of advanced ovarian cancer: a randomised co-operative multicentre phase III-study." @default.
- W2408804921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12530019" @default.
- W2408804921 hasPublicationYear "2003" @default.
- W2408804921 type Work @default.
- W2408804921 sameAs 2408804921 @default.
- W2408804921 citedByCount "3" @default.
- W2408804921 countsByYear W24088049212017 @default.
- W2408804921 crossrefType "journal-article" @default.
- W2408804921 hasAuthorship W2408804921A5007920312 @default.
- W2408804921 hasAuthorship W2408804921A5013581129 @default.
- W2408804921 hasAuthorship W2408804921A5032813803 @default.
- W2408804921 hasAuthorship W2408804921A5039080671 @default.
- W2408804921 hasAuthorship W2408804921A5047484440 @default.
- W2408804921 hasAuthorship W2408804921A5054137171 @default.
- W2408804921 hasAuthorship W2408804921A5054580261 @default.
- W2408804921 hasAuthorship W2408804921A5063493469 @default.
- W2408804921 hasConcept C126322002 @default.
- W2408804921 hasConcept C141071460 @default.
- W2408804921 hasConcept C2776694085 @default.
- W2408804921 hasConcept C2776755627 @default.
- W2408804921 hasConcept C2779178397 @default.
- W2408804921 hasConcept C2779263901 @default.
- W2408804921 hasConcept C29730261 @default.
- W2408804921 hasConcept C535046627 @default.
- W2408804921 hasConcept C61943457 @default.
- W2408804921 hasConcept C71924100 @default.
- W2408804921 hasConcept C90924648 @default.
- W2408804921 hasConceptScore W2408804921C126322002 @default.
- W2408804921 hasConceptScore W2408804921C141071460 @default.
- W2408804921 hasConceptScore W2408804921C2776694085 @default.
- W2408804921 hasConceptScore W2408804921C2776755627 @default.
- W2408804921 hasConceptScore W2408804921C2779178397 @default.
- W2408804921 hasConceptScore W2408804921C2779263901 @default.
- W2408804921 hasConceptScore W2408804921C29730261 @default.
- W2408804921 hasConceptScore W2408804921C535046627 @default.
- W2408804921 hasConceptScore W2408804921C61943457 @default.
- W2408804921 hasConceptScore W2408804921C71924100 @default.
- W2408804921 hasConceptScore W2408804921C90924648 @default.
- W2408804921 hasIssue "5" @default.
- W2408804921 hasLocation W24088049211 @default.
- W2408804921 hasOpenAccess W2408804921 @default.
- W2408804921 hasPrimaryLocation W24088049211 @default.
- W2408804921 hasRelatedWork W2002120878 @default.
- W2408804921 hasRelatedWork W2003938723 @default.
- W2408804921 hasRelatedWork W2019517015 @default.
- W2408804921 hasRelatedWork W2047967234 @default.
- W2408804921 hasRelatedWork W2118496982 @default.
- W2408804921 hasRelatedWork W2364998975 @default.
- W2408804921 hasRelatedWork W2369162477 @default.
- W2408804921 hasRelatedWork W2439875401 @default.
- W2408804921 hasRelatedWork W2519357708 @default.
- W2408804921 hasRelatedWork W2525756941 @default.
- W2408804921 hasVolume "22" @default.
- W2408804921 isParatext "false" @default.
- W2408804921 isRetracted "false" @default.
- W2408804921 magId "2408804921" @default.
- W2408804921 workType "article" @default.